
Nanotherapeutics Combating Microbial Infections and Antimicrobial Resistance
Volume 2 Nanotheranostics, Microbial Infections, and Antimicrobial Resistance
Academic Press
Published on 9. December 2025
Book
Paperback/Softback
462 pages
978-0-443-33070-4 (ISBN)
Description
Nanotherapeutics Combating Microbial Infections and Antimicrobial Resistance: Volume Two, Nanotheranostics, Microbial Infections, and Antimicrobial Resistance delves into the innovative use of nanotechnology to tackle antimicrobial resistance (AMR) and treat bacterial infections. The second volume of this series showcases cutting-edge nano-based solutions developed to overcome multi-drug resistant pathogens, offering insights from leading experts. This book is an essential resource for researchers, academics, students, industry professionals, and clinicians in fields related to microbiology, infectious diseases, and nanotechnology, providing a comprehensive overview of the latest advancements in the fight against bacterial infections.
Other noteworthy highlights of this book include contributions from experts, informative references, and emerging technologies aimed at both treating and preventing the progression of bacterial infections. This volume is particularly valuable for those interested in the intersection of nanotechnology and healthcare.
Other noteworthy highlights of this book include contributions from experts, informative references, and emerging technologies aimed at both treating and preventing the progression of bacterial infections. This volume is particularly valuable for those interested in the intersection of nanotechnology and healthcare.
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
College/higher education
Dimensions
Height: 235 mm
Width: 191 mm
Weight
450 gr
ISBN-13
978-0-443-33070-4 (9780443330704)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Divakar Sharma | Indu Singh
Nanotherapeutics Combating Microbial Infections and Antimicrobial Resistance
Volume 2 - Nanotheranostics, Microbial Infections, and Antimicrobial Resistance
E-Book
12/2025
Elsevier
€163.99
Available for download
Persons
Dr. Divakar Sharma, doctorate from the National JALMA Institute for leprosy and other Mycobacterial diseases, Agra (ICMR) & Jiwaji University, Gwalior, India. He has more than 16 years of experience in the field of Infectious Diseases and Antimicrobial resistance (AMR). Currently, Dr Sharma is working as an Associate Professor at the Department of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, 248002, India. He has published more than 90 articles and book chapters in international journals and books. He also edited several books for Springer, Elsevier, and Bentham Science Publishers. He also serves as an associate editor in various international journals of Wiley, BMC, Frontiers, Sage, and Bentham Science publishers. He is also having various national awards and fellowships. Dr Sharma's profile has been listed in the top 2% of the world's scientists by Stanford University in 2023 and 2024.
Dr. Indu Singh is an Assistant Professor at the School of Pharmacy, Graphic Era Hill University, Dehradun. She previously served at K. R. Mangalam University, Gurugram, as an Assistant Professor in Pharmacology and a Research Communication Officer. A Pharmacologist and Biomedical Scientist, Dr. Singh earned her PhD from the University of Delhi, and her postgraduation in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where she was a Gold Medalist.
Her research focuses on nanomedicine development for combating Antimicrobial Resistance (AMR) and Biofilm-Associated Infections (BAI), as well as therapeutic strategies for Autism Spectrum Disorder (ASD) targeting inflammatory markers. She has 15+ publications, serves as an editor and reviewer for international journals, and has received multiple honors, including the Young Scientist Award from Kasetsart University, Thailand, and seven national awards. Dr. Singh has organized and contributed to national and international workshops, including the DST INDO-ASEAN Workshop, and has mentored PG, UG, and Ph.D. students. She has also edited one academic book.
Dr. Indu Singh is an Assistant Professor at the School of Pharmacy, Graphic Era Hill University, Dehradun. She previously served at K. R. Mangalam University, Gurugram, as an Assistant Professor in Pharmacology and a Research Communication Officer. A Pharmacologist and Biomedical Scientist, Dr. Singh earned her PhD from the University of Delhi, and her postgraduation in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where she was a Gold Medalist.
Her research focuses on nanomedicine development for combating Antimicrobial Resistance (AMR) and Biofilm-Associated Infections (BAI), as well as therapeutic strategies for Autism Spectrum Disorder (ASD) targeting inflammatory markers. She has 15+ publications, serves as an editor and reviewer for international journals, and has received multiple honors, including the Young Scientist Award from Kasetsart University, Thailand, and seven national awards. Dr. Singh has organized and contributed to national and international workshops, including the DST INDO-ASEAN Workshop, and has mentored PG, UG, and Ph.D. students. She has also edited one academic book.
Editor
Department of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, 248002, India
School of Pharmacy, Graphic Era Hill University, Dehradun, 248002, India
Content
1. A Brief Introduction to Nanotherapeutics: A Magic Bullet for Bacterial Infections
2. Nanotherapeutics: Advancement in Technology and Applications Against Microbes
3. Nanobiotics to Combat the Antimicrobial Resistance
4. Green Chemistry Based Nanoarchitectures Culminating Bacterial Ailments
5. Nano-Based Treatment Against Infections in Hospital Settings
6. Nano-Derived Materials to Fight Biofilm-Forming Microbial Communities
7. Nano-Based Formulations Treating M. Tuberculosis and Its Resistant Strains
8. Nano-Based Strategies to Combat Bacterial Pneumonia
9. Nano-Based Intervention Against Methicillin Resistant Staphylococcus Aureus
10. Nanotherapeutics to Combat Multidrug Resistant ESKAPE Pathogens
11. Chemically and Biogenically Derived Nanosheets: A Prominent Battleground Against Antimicrobial Resistance
12. The Effect of Mechanical Energy-Based Bacterial Killing on the Metal-Nano Framework
13. Antimicrobial Therapy Using Quantum Dots Combined with an Aggravating Light Activated Photosensitizer: An Emerging Paradigm
14. Antimicrobial Peptide Conjugated Nanoaggregates for Tackling Biofilm Progression and the Microbial Population
15. Biomolecule Functionalized Nanostructures Targeting Bacterial Infectious Diseases and Associated Biofilm Formation
16. Polydopamine Assisted Drug Conjugates as Double Sword for Bacterial Infection and Biofilm Progression
17. Liposome Derived Nanotherapeutics Against Drug Resistant Microbes
18. Smart Nanotherapeutics Against Chronic Infections
19. Nanorobotics and Artificial Intelligence for Effective Nano-Based Intervention
2. Nanotherapeutics: Advancement in Technology and Applications Against Microbes
3. Nanobiotics to Combat the Antimicrobial Resistance
4. Green Chemistry Based Nanoarchitectures Culminating Bacterial Ailments
5. Nano-Based Treatment Against Infections in Hospital Settings
6. Nano-Derived Materials to Fight Biofilm-Forming Microbial Communities
7. Nano-Based Formulations Treating M. Tuberculosis and Its Resistant Strains
8. Nano-Based Strategies to Combat Bacterial Pneumonia
9. Nano-Based Intervention Against Methicillin Resistant Staphylococcus Aureus
10. Nanotherapeutics to Combat Multidrug Resistant ESKAPE Pathogens
11. Chemically and Biogenically Derived Nanosheets: A Prominent Battleground Against Antimicrobial Resistance
12. The Effect of Mechanical Energy-Based Bacterial Killing on the Metal-Nano Framework
13. Antimicrobial Therapy Using Quantum Dots Combined with an Aggravating Light Activated Photosensitizer: An Emerging Paradigm
14. Antimicrobial Peptide Conjugated Nanoaggregates for Tackling Biofilm Progression and the Microbial Population
15. Biomolecule Functionalized Nanostructures Targeting Bacterial Infectious Diseases and Associated Biofilm Formation
16. Polydopamine Assisted Drug Conjugates as Double Sword for Bacterial Infection and Biofilm Progression
17. Liposome Derived Nanotherapeutics Against Drug Resistant Microbes
18. Smart Nanotherapeutics Against Chronic Infections
19. Nanorobotics and Artificial Intelligence for Effective Nano-Based Intervention